These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9578496)

  • 1. Activating mutations of the thyrotropin receptor: a short review with emphasis on some pediatric aspects.
    Polak M
    Eur J Endocrinol; 1998 Apr; 138(4):353-7. PubMed ID: 9578496
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetic hyperthyroidism: hyperthyroidism due to activating TSHR mutations.
    Hébrant A; van Staveren WC; Maenhaut C; Dumont JE; Leclère J
    Eur J Endocrinol; 2011 Jan; 164(1):1-9. PubMed ID: 20926595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Activating mutations of the TSH receptor: a synthesis highlighting certain pediatric aspects].
    Polak M
    Arch Pediatr; 1998; 5 Suppl 4():375S-379S. PubMed ID: 9853087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathology of the TSH receptor.
    Duprez L; Parma J; Van Sande J; Rodien P; Sabine C; Abramowicz M; Dumont JE; Vassart G
    J Pediatr Endocrinol Metab; 1999 Apr; 12 Suppl 1():295-302. PubMed ID: 10698593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Non-autoimmune hyperthyroidism and hyperfunctioning thyroid adenomas caused by activating mutation of the thyrotropin receptor].
    Kosugi S
    Nihon Rinsho; 2002 Feb; 60(2):291-6. PubMed ID: 11857916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Congenital hyperthyroidism caused by a solitary toxic adenoma harboring a novel somatic mutation (serine281-->isoleucine) in the extracellular domain of the thyrotropin receptor.
    Kopp P; Muirhead S; Jourdain N; Gu WX; Jameson JL; Rodd C
    J Clin Invest; 1997 Sep; 100(6):1634-9. PubMed ID: 9294132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brief report: congenital hyperthyroidism caused by a mutation in the thyrotropin-receptor gene.
    Kopp P; van Sande J; Parma J; Duprez L; Gerber H; Joss E; Jameson JL; Dumont JE; Vassart G
    N Engl J Med; 1995 Jan; 332(3):150-4. PubMed ID: 7800007
    [No Abstract]   [Full Text] [Related]  

  • 8. Thyrotropin receptor mutations in thyroid diseases.
    Yen PM
    Rev Endocr Metab Disord; 2000 Jan; 1(1-2):123-9. PubMed ID: 11704987
    [No Abstract]   [Full Text] [Related]  

  • 9. Sporadic nonautoimmune congenital hyperthyroidism due to a strong activating mutation of the thyrotropin receptor gene.
    Tonacchera M; Agretti P; Rosellini V; Ceccarini G; Perri A; Zampolli M; Longhi R; Larizza D; Pinchera A; Vitti P; Chiovato L
    Thyroid; 2000 Oct; 10(10):859-63. PubMed ID: 11081252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperfunctioning thyroid adenoma and activating mutations in the TSH receptor gene.
    Polak M
    Arch Med Res; 1999; 30(6):510-3. PubMed ID: 10714365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activating mutations of the TSH receptor gene cause thyroid diseases.
    Vassart G; Van Sande J; Parma J; Tonacchera M; Duprez L; Swillens S; Dumont J
    Ann Endocrinol (Paris); 1996; 57(1):50-4. PubMed ID: 8734289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activating TSH-receptor mutation (Met453Thr) as a cause of adenomatous non-autoimmune hyperthyroidism in a 3-year-old boy.
    Kraemer S; Rothe K; Pfaeffle R; Fuehrer-Sakel D; Till H; Muensterer OJ
    J Pediatr Endocrinol Metab; 2009 Mar; 22(3):269-74. PubMed ID: 19492584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constitutively activating TSH receptor mutations as the cause of toxic thyroid adenoma, multinodular toxic goiter and autosomal dominant non autoimmune hyperthyroidism.
    Paschke R
    Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 4():129-32. PubMed ID: 8981020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activating mutations of TSH receptor.
    Rodien P; Ho SC; Vlaeminck V; Vassart G; Costagliola S
    Ann Endocrinol (Paris); 2003 Feb; 64(1):12-6. PubMed ID: 12707626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sporadic nonautoimmune neonatal hyperthyroidism due to A623V germline mutation in the thyrotropin receptor gene.
    Aycan Z; Ağladıoğlu SY; Ceylaner S; Cetinkaya S; Baş VN; Kendirici HN
    J Clin Res Pediatr Endocrinol; 2010; 2(4):168-72. PubMed ID: 21274318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autosomal dominant nonautoimmune hyperthyroidism. Clinical features-diagnosis-therapy.
    Führer D; Mix M; Willgerodt H; Holzapfel HP; Von Petrykowski W; Wonerow P; Paschke R
    Exp Clin Endocrinol Diabetes; 1998; 106 Suppl 4():S10-5. PubMed ID: 9867189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A somatic gain-of-function mutation in the thyrotropin receptor gene producing a toxic adenoma in an infant.
    Kohn B; Grasberger H; Lam LL; Ferrara AM; Refetoff S
    Thyroid; 2009 Feb; 19(2):187-91. PubMed ID: 19191749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular insights into TSH receptor abnormality and thyroid disease.
    Russo D; Arturi F; Chiefari E; Filetti S
    J Endocrinol Invest; 1997 Jan; 20(1):36-47. PubMed ID: 9075071
    [No Abstract]   [Full Text] [Related]  

  • 19. The TSH receptor mutation database.
    Trültzsch B; Nebel T; Paschke R
    Eur J Endocrinol; 1999 Jun; 140(6):VII. PubMed ID: 10428577
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification of a new thyrotropin receptor germline mutation (Leu629Phe) in a family with neonatal onset of autosomal dominant nonautoimmune hyperthyroidism.
    Führer D; Wonerow P; Willgerodt H; Paschke R
    J Clin Endocrinol Metab; 1997 Dec; 82(12):4234-8. PubMed ID: 9398746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.